Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the page history, and v3.4.3 is shown as a deletion.
    Difference
    0.0%
    Check dated 2026-03-18T20:24:17.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:16:41.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The Study Status and Recruitment Status were updated to Completed, replacing the previous Active, not recruiting status.
    Difference
    0.2%
    Check dated 2026-02-25T08:46:42.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The history adds Revision: v3.4.2 and removes a government-funding/operating-status notice and Revision: v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T09:28:59.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and an updated site revision (v3.4.1) appear in the history; both are administrative updates and do not affect trial data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T06:19:06.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle, green highlights for additions and red highlights for deletions, and an updated revision badge (v3.4.0), with No FEAR Act data text removed and older revision text (v3.3.4) removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T04:19:46.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.